Arkolith/Insider Trading/UBX/Form 4

Nguyen Alexander Hieu

See RemarksUnity Biotechnology, Inc. (UBX) · full profile →Form 4 · filed May 12, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
0 non-derivative · 5 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 11, 2023Grant(A)2K—$02K
May 11, 2023Grant(A)40K$2.77$111K40K
May 11, 2023Disposed to issuer(D)2K—$00
May 11, 2023Grant(A)18K—$018K
May 11, 2023Disposed to issuer(D)18K—$00

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-23-012901) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML